The global infectious disease molecular diagnostics market is experiencing extraordinary growth, driven by the rising demand for rapid and precise diagnostic tools in the healthcare sector. Valued at ...

Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.

Advances in high-throughput phenotyping (HTP) platforms together with genotyping technologies have revolutionized breeding of ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...

Should you venture into a Toronto grocery store in the depths of winter and purchase a pint of strawberries, chances are the ...

There are new findings out about the benefits of eating walnuts. Results from a UConn School of Medicine clinical trial on ...

New research highlights how 1.6 THz radiation selectively reduces DNA methylation in cancer cells. Discover the potential of ...

The scientific team at JuveXO®, one of the most advanced exosome-based solutions available today, is thrilled to announce the ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced the launch of Oncodetecttm?a new test designed to detect molecular residual disease (MRD) across ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch ...

The global molecular diagnostic market size is projected to increase from USD 368.53 million in 2025 and is estimated to be worth around USD 542.97 m ...

Given that only a small fraction of patients with cancer exhibits specific markers making them eligible for effective ...